News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,718 Results
Type
Article (13821)
Company Profile (112)
Press Release (248785)
Section
Business (88567)
Career Advice (473)
Deals (15509)
Drug Delivery (64)
Drug Development (36768)
Employer Resources (50)
FDA (6300)
Job Trends (6279)
News (151108)
Policy (14108)
Tag
Academia (442)
Alliances (23202)
Alzheimer's disease (347)
Approvals (6288)
Artificial intelligence (54)
Bankruptcy (148)
Best Places to Work (4344)
Biosimilars (38)
Biotechnology (46)
Breast cancer (35)
Cancer (273)
Career advice (416)
Cell therapy (39)
Clinical research (30442)
Collaboration (121)
Compensation (51)
COVID-19 (767)
C-suite (38)
Data (258)
Diabetes (46)
Diagnostics (1250)
Drug pricing (60)
Earnings (31427)
Employer resources (44)
Events (36856)
Executive appointments (137)
FDA (6453)
Funding (88)
Gene therapy (57)
GLP-1 (294)
Government (1278)
Healthcare (3610)
Infectious disease (783)
Inflammatory bowel disease (45)
Interviews (60)
IPO (5870)
Job creations (2091)
Job search strategy (382)
Layoffs (168)
Legal (3439)
Lung cancer (40)
Manufacturing (82)
Medical device (1309)
Medtech (1311)
Mergers & acquisitions (9632)
Metabolic disorders (155)
Neuroscience (433)
NextGen Class of 2024 (1630)
Non-profit (618)
Northern California (358)
Obesity (99)
Opinion (109)
Patents (50)
People (28588)
Pharmaceutical (65)
Phase I (7932)
Phase II (12867)
Phase III (11580)
Pipeline (87)
Podcasts (38)
Policy (45)
Postmarket research (1401)
Preclinical (3179)
Radiopharmaceuticals (117)
Rare diseases (74)
Real estate (2695)
Regulatory (9847)
Research institute (577)
Resumes & cover letters (55)
Southern California (367)
Startups (1648)
United States (3609)
Vaccines (113)
Weight loss (80)
Date
Today (77)
Last 7 days (271)
Last 30 days (994)
Last 365 days (13048)
2024 (10778)
2023 (14384)
2022 (19802)
2021 (20377)
2020 (19297)
2019 (15117)
2018 (11859)
2017 (13986)
2016 (13251)
2015 (15576)
2014 (12518)
2013 (10654)
2012 (11462)
2011 (11994)
2010 (10934)
Location
Africa (314)
Arizona (39)
Asia (19832)
Australia (2568)
California (831)
Canada (541)
China (94)
Connecticut (34)
Europe (38809)
Florida (115)
Illinois (94)
Indiana (78)
Kansas (50)
Maryland (136)
Massachusetts (723)
Minnesota (47)
New Jersey (348)
New York (236)
North Carolina (261)
Northern California (358)
Ohio (36)
Pennsylvania (247)
South America (501)
Southern California (367)
Texas (111)
Washington State (64)
262,718 Results for "slate pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)
Gritstone bio, Inc., a clinical-stage biotechnology company working to develop the world’s most potent vaccines, announced that a paper detailing the development of its “off-the-shelf” neoantigen platform, SLATE, recently published in Nature Medicine.
April 15, 2024
·
7 min read
M&A
Roivant Deals Again, Sending Dermavant to Organon in Sale Worth Up to $1.2B
The sale of Dermavant clears the way for Roivant to focus on autoimmune-focused Immunovant and a slate of upcoming pivotal trials.
September 18, 2024
·
3 min read
·
Annalee Armstrong
Business
Envoy Medical Announces Proposed Board Slate of Experienced Medical Device and Financial Leaders
Envoy Medical® Corporation (“Envoy”), a hearing health company, today announced the proposed slate of seven directors to be voted on during the special meeting of stockholders to be held by its merger partner
September 19, 2023
·
15 min read
Genetown
Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Prevalence of Obesity in Obstructive Sleep Apnea
Apnimed, Inc. announced a series of five data presentations and a dinner symposium at the SLEEP 2024 annual meeting.
May 23, 2024
·
8 min read
Business
Maryland Tech Council Welcomes New Chair and Slate of Industry Leaders to its Board of Directors
The Maryland Tech Council, the largest technology and life sciences trade association in the state, welcomed a new chair and slate of technology and life sciences leaders to its board of directors.
July 11, 2023
·
3 min read
Biotech Bay
Epic Bio Announces Robust Slate of Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced the acceptance of six abstracts, three oral presentations, and three poster presentations at the upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 7-11, 2024, in Baltimore, Maryland.
April 9, 2024
·
2 min read
Business
Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension
Frontier Medicines Corporation announced the appointment of Gerardo Ubaghs as Chief Financial Officer and the additional close of $20 million extension to its Series C, bringing the total amount raised to $100 million, with the financing slated to accelerate multiple pipeline programs.
June 25, 2024
·
3 min read
Drug Development
J&J Inks $1.25B Deal to Buy Rights to Atopic Dermatitis Candidate from Numab
Johnson & Johnson’s deal for Numab Therapeutics’ bispecific antibody NM26, slated to enter Phase II studies, comes on the heels of J&J’s $850 million Proteologix bispecific antibody acquisition.
May 28, 2024
·
2 min read
·
Tyler Patchen
Biotech Beach
Anna Richo joins Illumina’s Board of Directors - May 20, 2024
Illumina, Inc. announced that Anna Richo has joined the company’s Board of Directors following shareholder approval of the director slate at the company’s May 16, 2024, annual meeting.
May 20, 2024
·
2 min read
BioCapital
Maryland Life Sciences Announces First Slate of Speakers for 2022 Bio Innovation Conference
Maryland Life Sciences, a division of the Maryland Tech Council, is pleased to announce the first slate of speakers for its 2022 Bio Innovation Conference.
September 14, 2022
·
3 min read
1 of 26,272
Next